April 2024 FDA Recall Haloperidol Decanoate by Somerset Therapeutics Llc
D-0506-2024 - Presence of Foreign Substance

This Class II drug recall was voluntarily initiated by Somerset Therapeutics Llc on April 24, 2024 for the product Haloperidol Decanoate. The FDA reported the reason for recall as presence of foreign substance. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0506-2024

Reason for Recall
Presence of Foreign Substance: This oil based product may contain trace amounts of water for injection (WFI).
Initiated
04-24-2024
Reported
05-29-2024
Quantity
5,578 units

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
SOMERSET THERAPEUTICS LLC
Nationwide within the United States
Haloperidol decanoate Injection 50mg/mL, packaged in a) 1 mL Single-Dose Vials (NDC 70069-381-01) and b) 10 1mL Single-Dose Vials (NDC 70069-381-10), Rx only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India.

Batch or Lot Expiration Information

Lot# : a) A230412A, Exp. Date 07/2025; b)A230412B, Exp. Date 07/2025